ADMA BIOLOGICS INC - COMMON STOCK

NetDania - New 12 months High: ADMA BIOLOGICS INC - COMMON STOCK

30 Sep 2024 08:06:12 By NetDania Notify

ADMA Biologics Set to Join S&P SmallCap 600 Index

17 Sep 2024 04:00:00 By Nasdaq GlobeNewswire

ADMA Biologics to Participate in the 2024 Cantor Global Healthcare Conference

10 Sep 2024 04:00:00 By Nasdaq GlobeNewswire

ADMA Biologics Announces Partial Paydown of Revolving Credit Facility

14 Aug 2024 05:59:22 By Nasdaq GlobeNewswire

ADMA Biologics Announces Second Quarter 2024 Financial Results and Provides Business Update

08 Aug 2024 13:05:01 By Nasdaq GlobeNewswire

ADMA Biologics to Report Second Quarter 2024 Financial Results on August 8, 2024

01 Aug 2024 04:00:00 By Nasdaq GlobeNewswire

ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update

09 May 2024 13:05:01 By Nasdaq GlobeNewswire

ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024

02 May 2024 04:00:01 By Nasdaq GlobeNewswire

ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®

11 Mar 2024 04:00:00 By Nasdaq GlobeNewswire

ADMA Biologics to Participate in the Raymond James Institutional Investor Conference

05 Mar 2024 04:00:00 By Nasdaq GlobeNewswire

ADMA Biologics Announces CFO Transition

28 Feb 2024 13:10:00 By Nasdaq GlobeNewswire

ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

28 Feb 2024 13:05:00 By Nasdaq GlobeNewswire

ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

21 Feb 2024 13:05:00 By Nasdaq GlobeNewswire

ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlytics

21 Feb 2024 04:00:00 By Nasdaq GlobeNewswire

ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business Update

08 Jan 2024 04:00:01 By Nasdaq GlobeNewswire

ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares Management

18 Dec 2023 13:05:00 By Nasdaq GlobeNewswire

ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Years of Age and Older

12 Dec 2023 04:00:00 By Nasdaq GlobeNewswire

ADMA BioCenters Receives FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MD

16 Nov 2023 04:00:00 By Nasdaq GlobeNewswire

ADMA Biologics Announces Third Quarter 2023 Financial Results and Provides Business Update

08 Nov 2023 13:05:01 By Nasdaq GlobeNewswire

ADMA Biologics to Report Third Quarter 2023 Financial Results on November 8, 2023

01 Nov 2023 04:00:00 By Nasdaq GlobeNewswire